We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

37 hedge funds and large institutions have $19.9M invested in Capricor Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

199% more call options, than puts

Call options by funds: $1.36M | Put options by funds: $455K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

9% more funds holding

Funds holding: 34 → 37 (+3)

5% more capital invested

Capital invested by funds: $18.9M → $19.9M (+$952K)

8.27% less ownership

Funds ownership: 21.48% → 13.21% (-8.3%)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
8
Closed
3
Calls
$1.36M
Puts
$455K
Net Calls
+$907K
Net Calls Change
+$671K

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$2.96M
2
Osaic Holdings
Osaic Holdings
Arizona
+$360K
3
Renaissance Technologies
Renaissance Technologies
New York
+$338K
4
JF
Jump Financial
Illinois
+$172K
5
Morgan Stanley
Morgan Stanley
New York
+$171K

Top Sellers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
-$9.54M
2
Citigroup
Citigroup
New York
-$123K
3
Group One Trading
Group One Trading
Illinois
-$111K
4
Millennium Management
Millennium Management
New York
-$77.3K
5
Citadel Advisors
Citadel Advisors
Florida
-$67.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
CBA
26
Coastal Bridge Advisors
Connecticut
$53.3K – – –
YIH
27
Y-Intercept (HK)
Hong Kong
$50.2K +$33.4K +10,263 New
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$49K +$27.9K +8,578 +613%
US Bancorp
29
US Bancorp
Minnesota
$36.5K – – –
Group One Trading
30
Group One Trading
Illinois
$9.81K -$111K -33,962 -94%
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.45K – – –
HGERS
32
Householder Group Estate & Retirement Specialist
Arizona
$7K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$6.65K -$24.6K -7,562 -85%
HIIFS
34
Harel Insurance Investments & Financial Services
Israel
$3K – – –
MSWM
35
McGlone Suttner Wealth Management
Wisconsin
$2.07K +$1.38K +423 New
Wells Fargo
36
Wells Fargo
California
$1.15K +$156 +48 +26%
NMG
37
New Millennium Group
Utah
$289 – – –
HCM
38
Highbridge Capital Management
New York
– -$9.54M -2,789,699 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$67.9K -20,861 Closed
CG
40
Cutler Group
California
– -$3K -1,000 Closed
1
2

CAPR Hedge Fund Activity: Q4 2023 in Review

37 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q4 2023, worth a combined $19.9M — up 5% from $18.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CAPR positions and 3 closed out — a net gain of 3 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $2.96M. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $9.54M sold.

  • 37 institutional investors held Capricor Therapeutics (CAPR) as of Q4 2023, up from 34 in Q3 2023.
  • Funds reported $19.9M of Capricor Therapeutics stock for Q4 2023, up 5% quarter-over-quarter.
  • 6 funds opened new Capricor Therapeutics positions in Q4 2023 and 3 closed out, a net change of +3 holders.
  • The largest Capricor Therapeutics buyer in Q4 2023 was Woodline Partners, an estimated $2.96M added.
  • The largest Capricor Therapeutics seller in Q4 2023 was Highbridge Capital Management, an estimated $9.54M sold.

Based on aggregated 13F filings for Q4 2023.